No Data
No Data
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
60 Degrees Pharmaceuticals 3Q Loss/Shr 93c >SXTP
Express News | 60 Degrees Q3 2024 GAAP EPS $(0.93) Misses $(0.70) Estimate, Sales $135.00K Miss $242.00K Estimate
Express News | 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
10-Q: Q3 2024 Earnings Report
60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Announced Commenced a Nine-month ARAKODA Promotional Pilot.
No Data
No Data